Your session is about to expire
← Back to Search
Alkylating Agent
Docetaxel + Carboplatin for Ovarian Cancer
Phase 2
Waitlist Available
Research Sponsored by Herbert Irving Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Renal: BUN less than 1.5 times normal, Creatinine less than 1.5 times ULN
Suboptimally debulked stage III or suboptimally or optimally debulked stage IV
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Study Summary
This trial is studying how well giving carboplatin and docetaxel together works in treating patients with ovarian, fallopian tube, or primary peritoneal cancer.
Who is the study for?
This trial is for adults with stage III or IV ovarian, fallopian tube, or primary peritoneal cancer that hasn't been treated before. Participants should have a certain level of CA 125 protein and can't be part of another major study. They must not have other serious illnesses, no recent cancers except some skin cancers or cervical carcinoma in situ, and they need to use effective contraception if fertile.Check my eligibility
What is being tested?
The trial is testing the combination of two chemotherapy drugs: docetaxel and carboplatin. It's a Phase II study which means it's looking at how well these drugs work together to treat patients with advanced stages of specific types of cancer.See study design
What are the potential side effects?
Chemotherapy drugs like docetaxel and carboplatin can cause side effects such as nausea, fatigue, hair loss, low blood cell counts leading to increased infection risk or bleeding problems, nerve damage causing numbness or tingling sensations.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My kidney function tests are within normal limits.
Select...
My surgery for stage III or IV cancer didn't remove all the cancer.
Select...
I have a confirmed diagnosis of ovarian, fallopian tube, uterine, or peritoneal cancer that has not been treated.
Select...
I am over 18 years old.
Select...
I am fully active or can carry out light work.
Select...
My cancer can be measured or seen on tests.
Select...
I do not have any serious health or mental health conditions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Find a Location
Who is running the clinical trial?
Herbert Irving Comprehensive Cancer CenterLead Sponsor
33 Previous Clinical Trials
889 Total Patients Enrolled
1 Trials studying Endometrial Cancer
25 Patients Enrolled for Endometrial Cancer
Amy D. Tiersten, MDStudy ChairHerbert Irving Comprehensive Cancer Center
5 Previous Clinical Trials
159 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have not had chemotherapy before.My kidney function tests are within normal limits.I am not currently on hormone therapy.I haven't had any cancer except for treated skin or cervical cancer in the last 5 years.I have not had any radiation treatment before.My liver function tests are within the required limits.My surgery for stage III or IV cancer didn't remove all the cancer.I am not receiving any other chemotherapy treatments.My cancer's measurable areas don't include CNS, certain bone lesions, or previously radiated areas unless they've worsened.I have a confirmed diagnosis of ovarian, fallopian tube, uterine, or peritoneal cancer that has not been treated.I am over 18 years old.I am fully active or can carry out light work.My cancer can be measured or seen on tests.I do not have any serious health or mental health conditions.
Research Study Groups:
This trial has the following groups:Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are investigators still looking for new participants for this trial?
"According to the official website, this clinical trial is not presently looking for volunteers. This specific study was first posted on 5/1/1998 but has since been edited on 1/3/2014. Even though this particular trial is no longer active, there are still 740 other clinical trials that are currently seeking patients."
Answered by AI
Has this therapy been cleared for use by the FDA?
"While there is some data indicating this treatment's safety, it is still in Phase 2 of clinical trials and has not yet been proven effective. Therefore, our team rates its safety as a 2."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger